DCT has tendency to produce higher IOP results

Article

Intraocular pressure (IOP) is higher when measured by dynamic contour tonometry (DCT) rather than Goldmann applanation tonometry (GAT).

Intraocular pressure (IOP) is higher when measured by dynamic contour tonometry (DCT) rather than Goldmann applanation tonometry (GAT), according to a study published in the Journal of Glaucoma.

An investigation led by Dr Guy Regev, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, USA, assessed the central corneal thickness (CCT) and GAT as well as DCT measurements in 116 open-angle glaucoma patients. GAT and DCT were evaluated in a randomized order, along with CCT in a single study visit. The agreement between GAT and DCT measurements were evaluated using Bland-Altman plots and the influence of CCT on IOP measurements was evaluated by multivariate regression analysis.

The findings revealed that using DCT to measure IOP was significantly higher than in GAT. There was a strong positive correlation between DCT and GAT IOP measurements in open-angle glaucoma patients. The Bland-Altman data demonstrated a variance on the amount of disagreement between the IOP measurement methods.

Both GAT and DCT measurements were not influenced by CCT. The results suggest there are alternative factors other than CCT as to why DCT produces significantly higher IOP results.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.